Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer

Affiliations

• ¹ Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
• ² Department of Psychiatry, Section of Medical Psychology and Psychotherapy, Erasmus Medical Centre, Rotterdam, The Netherlands.
• ³ Department of Clinical Epidemiology and Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, The Netherlands.
• ⁴ Department of Medical Oncology, Zuyderland Medical Centre, Geleen, The Netherlands.
• ⁵ Department of Trial Registration, Comprehensive Cancer Centre the Netherlands, Rotterdam, The Netherlands.
• ⁶ Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, The Netherlands.
• ⁷ Department of Medical Oncology, Erasmus Medical Centre, Rotterdam, The Netherlands.